000 01456 a2200397 4500
005 20250517232737.0
264 0 _c20191105
008 201911s 0 0 eng d
022 _a1432-1440
024 7 _a10.1007/s00109-018-1683-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBiswal, Manas R
245 0 0 _aCell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization.
_h[electronic resource]
260 _bJournal of molecular medicine (Berlin, Germany)
_c10 2018
300 _a1107-1118 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aChoroidal Neovascularization
_xtherapy
650 0 4 _aDependovirus
650 0 4 _aEndostatins
_xgenetics
650 0 4 _aGenetic Therapy
650 0 4 _aGenetic Vectors
650 0 4 _aHypoxia
650 0 4 _aMice, Inbred C57BL
650 0 4 _aParvovirinae
_xgenetics
650 0 4 _aRetinal Pigment Epithelium
_xmetabolism
700 1 _aPrentice, Howard M
700 1 _aSmith, George W
700 1 _aZhu, Ping
700 1 _aTong, Yao
700 1 _aDorey, C Kathleen
700 1 _aLewin, Alfred S
700 1 _aBlanks, Janet C
773 0 _tJournal of molecular medicine (Berlin, Germany)
_gvol. 96
_gno. 10
_gp. 1107-1118
856 4 0 _uhttps://doi.org/10.1007/s00109-018-1683-0
_zAvailable from publisher's website
999 _c28727694
_d28727694